Clark Hill Attorney James Shafer Publishes Article in Becker’s ASC Review
WASHINGTON, DC
– Attorney James Shafer, located in Clark Hill PLC’s Washington DC office, has recently published an article in Becker’s ASC Review. The article, entitled
Selling an ASC Ownership Interest to Physicians: Overview of Federal and State Laws and Regulations
, discusses the key federal and state laws and regulations involved in selling an ASC ownership interest to physicians.
Becker’s ASC Review provides practical business, legal, and clinical guidance for ambulatory surgery centers. Shafer’s article appeared October 1, 2010. To read the article, and for more information on Becker’s ASC Review, please go to http://www.beckersasc.com/stark-act-and-fraud-abuse-issues/selling-an-asc-ownership-interest-to-physicians-overview-of-federal-and-state-laws-and-regulations.html.
James M. Shafer
serves as “Of Counsel” in Clark Hill’s Health Care Practice Group practicing in the firm’s Washington, D.C. office, and is adjunct to the Corporate Practice Group. Shafer is admitted to practice in Indiana and Michigan and is not currently admitted to practice in Washington, DC. Shafer concentrates in the areas of corporate governance, business operations and transactions primarily for health systems, hospitals, behavioral health care centers, home health agencies, other ancillary service providers and physicians. He has also counseled several clients concerning venture capital investment transactions.
Shafer has extensive experience in representing and advising health care businesses and business owners. His experience includes entity choice, merger and acquisition, contractual review, physician – hospital alignment transactions, joint ventures, review for compliance with antitrust laws, securities laws and health care regulations.
In both the health care entity transaction and venture capital investment areas, Shafer has extensive experience representing both buyers and sellers in all phases of the transaction. Such experience includes identifying and qualifying potential acquisition targets, negotiation of transaction terms, drafting and negotiating all main and ancillary transaction documents, providing and performing all phases of due diligence, and managing the closings. He has been involved in and chaired angel, mezzanine and later round venture capital investments, primarily in emerging health technology companies.